Open‐Label Pilot Study of Interferon Gamma–1b in Patients With Non‐Infantile Osteopetrosis

The only treatment currently available for patients with severe infantile osteopetrosis is hematopoietic cell transplantation (HCT). HCT‐related toxicity and mortality risks typically preclude its use in non‐infantile patients, and other therapies are needed for these patients who have significant d...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Andrew, Miller, Weston P., Gupta, Ashish, Lund, Troy C., Schiferl, Daniel, Lam, Lok Sze Kelvin, Arzumanyan, Zorayr, Orchard, Paul J., Polgreen, Lynda E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914146/
https://www.ncbi.nlm.nih.gov/pubmed/35309862
http://dx.doi.org/10.1002/jbm4.10597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914146/
https://www.ncbi.nlm.nih.gov/pubmed/35309862
http://dx.doi.org/10.1002/jbm4.10597

Ejemplares similares